Invention Grant
- Patent Title: Anti-EFNA4 antibody-drug conjugates
-
Application No.: US15176452Application Date: 2016-06-08
-
Publication No.: US09872922B2Publication Date: 2018-01-23
- Inventor: Marc Isaac Damelin , Kiran Manohar Khandke , Puja Sapra , Alexander John Bankovich , Scott J. Dylla
- Applicant: PFIZER, INC. , ABBVIE STEMCENTRX LLC
- Applicant Address: US NY New York US IL North Chicago
- Assignee: Pfizer Inc.,AbbVie Stemcentrx LLC
- Current Assignee: Pfizer Inc.,AbbVie Stemcentrx LLC
- Current Assignee Address: US NY New York US IL North Chicago
- Agency: Womble Bond Dickinson (US) LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K47/48 ; A61K31/704 ; C07K16/30 ; A61K47/68
Abstract:
The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
Public/Granted literature
- US20170072066A1 ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES Public/Granted day:2017-03-16
Information query
